Literature DB >> 19326974

Histopathological changes in brain arteriovenous malformations after embolization using Onyx or N-butyl cyanoacrylate. Laboratory investigation.

Sabareesh Kumar Natarajan1, Donald Born, Basavaraj Ghodke, Gavin W Britz, Laligam N Sekhar.   

Abstract

OBJECT: The aim of this study was to analyze the histopathological changes in a consecutive series of 32 patients with brain arteriovenous malformations that were resected after undergoing endovascular embolization (22 using Onyx and 10 using N-butyl cyanoacrylate [NBCA]).
METHODS: Selections from fixed paraffin-embedded specimens were stained for histological examination with H & E and Verhoeff-van Gieson stain. Lipid dye Oil Red O was used to stain vessel specimens that were embolized using NBCA. Specimens were evaluated for the presence of embolic agent, inflammation, angionecrosis, and evidence of recanalization. These results were correlated with the time interval between the bleeding, embolization, and resection.
RESULTS: The smallest vessel occluded by the embolic agent was 5 microm in the Onyx group and 20 microm in the NBCA group. There was evidence of vascular or perivascular inflammation in 20 (90.9%) of 22 and 9 (90%) of 10 specimens after Onyx and NBCA embolization, respectively. Chronic foreign-body giant cells were observed in 12 (54.5%) of 22 specimens after Onyx embolization, but were absent in specimens after NBCA embolization. Angionecrosis of the embolized vessel was observed in 13 (59.1%) of 22 specimens and in 4 (40%) of 10 specimens after Onyx and NBCA embolization, respectively. There was evidence of recanalization in Onyx embolized vessels in 4 (18.2%) of 22 specimens, and there was no evidence of recanalization after NBCA embolization.
CONCLUSIONS: Onyx penetrates much smaller vessels than NBCA. Inflammation occurs with both embolic agents at equal frequency. Evidence of chronic foreign-body giant cells and recanalization after Onyx embolization shows a long-standing reaction to Onyx and raises questions about the permanence of occlusion after Onyx embolization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19326974     DOI: 10.3171/2008.12.JNS08441

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  22 in total

1.  Preliminary experience with precipitating hydrophobic injectable liquid in brain arteriovenous malformations.

Authors:  Naci Koçer; Hakan Hanımoğlu; Şebnem Batur; Sedat Giray Kandemirli; Osman Kızılkılıç; Zihni Sanus; Büge Öz; Civan Işlak; Mehmet Yaşar Kaynar
Journal:  Diagn Interv Radiol       Date:  2016 Mar-Apr       Impact factor: 2.630

2.  Seizures after Onyx embolization for the treatment of cerebral arteriovenous malformation.

Authors:  K de Los Reyes; A Patel; A Doshi; N Egorova; F Panov; J B Bederson; J A Frontera
Journal:  Interv Neuroradiol       Date:  2011-10-17       Impact factor: 1.610

3.  Recurrence of "cured" dural arteriovenous fistulas after Onyx embolization.

Authors:  Peter Adamczyk; Arun Paul Amar; William J Mack; Donald W Larsen
Journal:  Neurosurg Focus       Date:  2012-05       Impact factor: 4.047

4.  Experimental study of temperature-sensitive chitosan/β-glycerophosphate embolic material in embolizing the basicranial rete mirabile in swines.

Authors:  Xianbin Ning; Changfu Zhao; Jinfeng Pang; Zhaoyi Ding; Yubo Wang; Kan Xu; Hao Chen; Bingwei Li; Q I Luo
Journal:  Exp Ther Med       Date:  2015-05-07       Impact factor: 2.447

Review 5.  Advances in Biomaterials and Technologies for Vascular Embolization.

Authors:  Jingjie Hu; Hassan Albadawi; Brian W Chong; Amy R Deipolyi; Rahul A Sheth; Ali Khademhosseini; Rahmi Oklu
Journal:  Adv Mater       Date:  2019-06-06       Impact factor: 30.849

Review 6.  Polymeric materials for embolic and chemoembolic applications.

Authors:  Azadeh Poursaid; Mark Martin Jensen; Eugene Huo; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2016-02-26       Impact factor: 9.776

7.  Vascular Steal Syndrome, Optic Neuropathy, and Foreign Body Granuloma Reaction to Onyx-18 Embolization for Congenital Orbito-Facial Vascular Malformation.

Authors:  Catherine Y Liu; Marc A Yonkers; Tiffany S Liu; Don S Minckler; Jeremiah P Tao
Journal:  Ocul Oncol Pathol       Date:  2016-02-09

8.  Marginal sinus fistula supplied exclusively by vertebral artery feeders.

Authors:  Wondwossen G Tekle; Mikayel Grigoryan; Ramachandra P Tummala
Journal:  J Vasc Interv Neurol       Date:  2013-12

Review 9.  Vascular anomalies: classification, imaging characteristics and implications for interventional radiology treatment approaches.

Authors:  P R Mulligan; H J S Prajapati; L G Martin; T H Patel
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

10.  The usefulness of subcutaneous infiltration of epinephrine-containing lidocaine for curative transarterial embolization of dural arteriovenous fistula. A technical note.

Authors:  Shigeru Yamauchi; Akimasa Nishio; Yoshinobu Takahashi; Yutaka Mitsuhashi; Yuzo Terakawa; Taichiro Kawakami; Kenji Ohata
Journal:  Interv Neuroradiol       Date:  2014-02-10       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.